Compositions for stimulation of mammalian innate immune resistance to pathogens
AssigneeBoard of Regents, The University of Texas System
InventorsBURTON DICKEY, MICHAEL TUVIM, SCOTT EVANS
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a StIR composition to the individual.
Claims21
A composition comprising:
- (a) lipopeptide, (b) immune stimulatory oligodeoxy nucleotide, and (c) antiviral pharmaceutical.
A method of treating, inhibiting, or attenuating a viral infection comprising administering an effective amount of the composition comprising an aerosolized (a) lipopeptide and (b) immune stimulatory oligodeoxy nucleotide in combination with an orally administered composition comprising an anti-viral pharmaceutical to an individual that has or is at risk of viral infection.
A nebulizer comprising (a) lipopeptide, (b) immune stimulatory oligodeoxy nucleotide, and (c) anti-viral pharmaceutical.
Dependencies are inferred from the claim text.